Alexander J. Yi

Array ( [id] => 4903550 [patent_doc_number] => 20080112963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Ablative immunotherapy' [patent_app_type] => utility [patent_app_number] => 11/936221 [patent_app_country] => US [patent_app_date] => 2007-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6109 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20080112963.pdf [firstpage_image] =>[orig_patent_app_number] => 11936221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880543 [patent_doc_number] => 20080153926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING MITOCHONDRIAL ALDERHYDE DEHYDROGENASE-2' [patent_app_type] => utility [patent_app_number] => 11/868796 [patent_app_country] => US [patent_app_date] => 2007-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14728 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153926.pdf [firstpage_image] =>[orig_patent_app_number] => 11868796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6483152 [patent_doc_number] => 20100008928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'AGENT FOR PREVENTING/TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/444382 [patent_app_country] => US [patent_app_date] => 2007-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 75760 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20100008928.pdf [firstpage_image] =>[orig_patent_app_number] => 12444382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676147 [patent_doc_number] => 20080213777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Tumor suppressor pathway in C. elegans' [patent_app_type] => utility [patent_app_number] => 11/973006 [patent_app_country] => US [patent_app_date] => 2007-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17441 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213777.pdf [firstpage_image] =>[orig_patent_app_number] => 11973006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5574967 [patent_doc_number] => 20090142328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Uses of antileukoprotease in carcinoma' [patent_app_type] => utility [patent_app_number] => 11/906596 [patent_app_country] => US [patent_app_date] => 2007-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6633 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142328.pdf [firstpage_image] =>[orig_patent_app_number] => 11906596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867453 [patent_doc_number] => 20080146512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Cyclin-dependent kinase inhibitors as targets for opiod growth factor treatment' [patent_app_type] => utility [patent_app_number] => 11/901770 [patent_app_country] => US [patent_app_date] => 2007-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14930 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146512.pdf [firstpage_image] =>[orig_patent_app_number] => 11901770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4964848 [patent_doc_number] => 20080107668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'CYTOTOXIC T-LYMPHOCYTE-INDUCING IMMUNOGENS FOR PREVENTION, TREATMENT, AND DIAGNOSIS OF CANCER' [patent_app_type] => utility [patent_app_number] => 11/846872 [patent_app_country] => US [patent_app_date] => 2007-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18456 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107668.pdf [firstpage_image] =>[orig_patent_app_number] => 11846872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5348773 [patent_doc_number] => 20090004134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'KIT FOR TREATING A HEALTH CONDITION BY INDUCING TRANSLOCATION OF AN ERP57 PROTEIN TO A CELLULAR MEMBRANE' [patent_app_type] => utility [patent_app_number] => 11/845065 [patent_app_country] => US [patent_app_date] => 2007-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 13400 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004134.pdf [firstpage_image] =>[orig_patent_app_number] => 11845065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939587 [patent_doc_number] => 20080076906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Antagonists of neuropilin receptor function and use thereof' [patent_app_type] => utility [patent_app_number] => 11/893413 [patent_app_country] => US [patent_app_date] => 2007-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 17393 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076906.pdf [firstpage_image] =>[orig_patent_app_number] => 11893413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4570658 [patent_doc_number] => 07824678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'Antibodies against cancer antigen TMEFF2 and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/837337 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16481 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/824/07824678.pdf [firstpage_image] =>[orig_patent_app_number] => 11837337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903977 [patent_doc_number] => 20080113390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Personalized assay for the identification of an effective therapy for cancer' [patent_app_type] => utility [patent_app_number] => 11/891315 [patent_app_country] => US [patent_app_date] => 2007-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2690 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113390.pdf [firstpage_image] =>[orig_patent_app_number] => 11891315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823002 [patent_doc_number] => 20080227701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'ANTIANGIOGENIC POLYPEPTIDES AND METHODS FOR INHIBITING ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 11/829778 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10690 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227701.pdf [firstpage_image] =>[orig_patent_app_number] => 11829778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4669358 [patent_doc_number] => 20080044418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Tumor Antigens and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/782310 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 28607 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044418.pdf [firstpage_image] =>[orig_patent_app_number] => 11782310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682784 [patent_doc_number] => 20080249010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Method Of Inducing Apoptosis In Lymphoid Cells' [patent_app_type] => utility [patent_app_number] => 11/761942 [patent_app_country] => US [patent_app_date] => 2007-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8937 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249010.pdf [firstpage_image] =>[orig_patent_app_number] => 11761942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 190923 [patent_doc_number] => 07642234 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-05 [patent_title] => 'Beta-2-glycoprotein 1 is an inhibitor of angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/810521 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 31297 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/642/07642234.pdf [firstpage_image] =>[orig_patent_app_number] => 11810521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5354705 [patent_doc_number] => 20090186049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'METHOD OF TREATING MAGE POSITIVE CANCER' [patent_app_type] => utility [patent_app_number] => 12/301541 [patent_app_country] => US [patent_app_date] => 2007-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8485 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186049.pdf [firstpage_image] =>[orig_patent_app_number] => 12301541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5091687 [patent_doc_number] => 20070231326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Immunological Methods of Treating Cancer' [patent_app_type] => utility [patent_app_number] => 11/804182 [patent_app_country] => US [patent_app_date] => 2007-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21923 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231326.pdf [firstpage_image] =>[orig_patent_app_number] => 11804182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5258737 [patent_doc_number] => 20070212369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Colon Specific Genes and Proteins' [patent_app_type] => utility [patent_app_number] => 11/748211 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16867 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212369.pdf [firstpage_image] =>[orig_patent_app_number] => 11748211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5348741 [patent_doc_number] => 20090004102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease' [patent_app_type] => utility [patent_app_number] => 11/801415 [patent_app_country] => US [patent_app_date] => 2007-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 49724 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004102.pdf [firstpage_image] =>[orig_patent_app_number] => 11801415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5259107 [patent_doc_number] => 20070212739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Novel cancer-associated antigens and methods of their identification and use' [patent_app_type] => utility [patent_app_number] => 11/799584 [patent_app_country] => US [patent_app_date] => 2007-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14800 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212739.pdf [firstpage_image] =>[orig_patent_app_number] => 11799584 [rel_patent_id] =>[rel_patent_doc_number] =>)